pharma-investing blogspot.com

Investing In Pharmaceuticals

CV Therapeutics Wins FDA Approval. CV Therapeutics CVTX NASDAQ and Astellas Pharma Inc announced on Friday that the U.S. Food and Drug Administration has approved Lexiscan regadenoson, a heart imaging agent. Astellas signed a license agreement with CV Therapeutics for the development and sale of the agent in July 2007. CV Therapeutics, Astellas Heart-Monitor Drug Approved. FDA Approves Glaxos Rotarix For Infant Rotavirus. Orphan drug status is given to treatments for diseases affecting less than 200.

OVERVIEW

This web page pharma-investing.blogspot.com currently has a traffic ranking of zero (the lower the superior). We have explored eleven pages inside the domain pharma-investing.blogspot.com and found zero websites referring to pharma-investing.blogspot.com.
Pages Crawled
11

PHARMA-INVESTING.BLOGSPOT.COM RANKINGS

This web page pharma-investing.blogspot.com has seen a fluctuation levels of traffic within the past the year.
Traffic for pharma-investing.blogspot.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for pharma-investing.blogspot.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for pharma-investing.blogspot.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES PHARMA-INVESTING.BLOGSPOT.COM LOOK LIKE?

Desktop Screenshot of pharma-investing.blogspot.com Mobile Screenshot of pharma-investing.blogspot.com Tablet Screenshot of pharma-investing.blogspot.com

PHARMA-INVESTING.BLOGSPOT.COM HOST

Our parsers identified that a lone page on pharma-investing.blogspot.com took two hundred and ninety-seven milliseconds to come up. We could not find a SSL certificate, so our crawlers consider pharma-investing.blogspot.com not secure.
Load time
0.297 secs
SSL
NOT SECURE
Internet Protocol
172.217.10.129

WEBSITE IMAGE

SERVER OS AND ENCODING

I found that this domain is operating the GSE server.

PAGE TITLE

Investing In Pharmaceuticals

DESCRIPTION

CV Therapeutics Wins FDA Approval. CV Therapeutics CVTX NASDAQ and Astellas Pharma Inc announced on Friday that the U.S. Food and Drug Administration has approved Lexiscan regadenoson, a heart imaging agent. Astellas signed a license agreement with CV Therapeutics for the development and sale of the agent in July 2007. CV Therapeutics, Astellas Heart-Monitor Drug Approved. FDA Approves Glaxos Rotarix For Infant Rotavirus. Orphan drug status is given to treatments for diseases affecting less than 200.

CONTENT

This web page pharma-investing.blogspot.com states the following, "CV Therapeutics CVTX NASDAQ and Astellas Pharma Inc announced on Friday that the U." We saw that the webpage said " Food and Drug Administration has approved Lexiscan regadenoson, a heart imaging agent." It also said " Astellas signed a license agreement with CV Therapeutics for the development and sale of the agent in July 2007. CV Therapeutics, Astellas Heart-Monitor Drug Approved. FDA Approves Glaxos Rotarix For Infant Rotavirus. Orphan drug status is given to treatments for diseases affecting less than 200."

SEEK SIMILAR DOMAINS

Pharmaceuticals Biotechnology Pharma Biotech Resources

Data Science Makes for Better Lab Science. A panel of experts contemplate the path ahead for pharma innovation. 5 dangerous data integrity risks your lab may be taking. Learn from recent FDA investigation findings and warning letters.

פארמה ישראל ארגון חברות התרופות מבוססות מחקר ופיתוח

ארגון חברות התרופות מבוססות מחקר ופיתוח. הכנס השנתי למחקר ולניסויים קליניים,. 11 לאפריל, מלון דיויד אינטרקונטיננטל. קניין רוחני מתייחס אל מיגון הזכויות והכלים המגדירים זכויות בעלות בידע ובמידע. זהו שלב בפיתוח תרופות הבוחן את יעילותן ובטיחותן של תרופות לשימוש של בני אדם. רשימת השירותים הרפואיים הניתנים לתושבי ישראל דרך קופות החולים במימון המדינה כחוק. רגולציה בתחום התרופות התפתחה עקב דרישה ציבורית לפיקוח על מוצרי בטיחות ובריאות.

Pharma-Job, Jobsgning for Biotech, Medico og Pharmaceutisk industri

Opret din profil og vr med i oplbet, nr nogle af Danmarks mest spndende job i medicinal og biotek-branchen bliver besat. Du fr disse fordele ved at oprette din profil p. S snart du er oprettet fr du adgang til at sge. Blandt alle jobs i Pharma-Jobs database. Mske er dit drmme-job ledigt netop nu. Du vlger selv hvilke arbejdsgivere, du nsker dialog med. Du fr automatisk en mail, nr et nyt job p Pharma-Job matcher din profil. Eller ring 7023 8155 for mere information om jobannoncering hos Pharma-Job.

Tglich aktuelle Pharmajobs

Jobs und Stellenangebote aus der Pharmabranche.